Loading clinical trials...
Loading clinical trials...
A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Rilonacept for the Prophylaxis of Gout Flares During the Initiation of Allopurinol Therapy
Conditions
Interventions
Placebo
Rilonacept 80 mg
+1 more
Locations
91
United States
Birmingham, Alabama, United States
Gilbert, Arizona, United States
Peoria, Arizona, United States
Searcy, Arkansas, United States
Concord, California, United States
San Diego, California, United States
Start Date
February 1, 2009
Primary Completion Date
May 1, 2010
Completion Date
June 1, 2010
Last Updated
April 28, 2017
Lead Sponsor
Regeneron Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions